Risultati di ricerca
Thomas Andrew Daschle (/ ˈ d æ ʃ əl / DASH-əl; born December 9, 1947) is an American politician and lobbyist who represented South Dakota in the United States Senate from 1987 to 2005. A member of the Democratic Party , he led the Senate Democratic Caucus during the final ten years of his tenure, during which time he served as ...
Tom Daschle, vero nome Thomas Andrew Daschle (Aberdeen, 9 dicembre 1947), è un politico statunitense, senatore per lo stato del Dakota del Sud dal 1987 al 2005 e in precedenza membro della Camera dei rappresentanti per lo stesso stato dal 1979 al 1987.
Learn about the career and achievements of Senator Thomas A. Daschle, the founder and CEO of The Daschle Group, a public policy advisory firm. He served as a US Representative, a US Senator, a Senate Democratic Leader, and an author of several books on health care, climate change, and Cuba.
After serving for five years as an aide to Senator James Abourezk, Daschle ran a successful campaign for the House of Representatives in 1978 and served for eight years. In 1986 he won election to the U.S. Senate, where he focused on policy related to agriculture, American Indians, and healthcare.
3 mag 2024 · Tom Daschle (born Dec. 9, 1947, Aberdeen, S.D., U.S.) is an American politician who was a member of the U.S. Senate (1987–2005) and from 2001 to 2003 served as the Senate’s majority leader. Daschle was the first member of his family to attend college, and in 1969 he graduated from South Dakota State University with a B.A. in ...
- The Editors of Encyclopaedia Britannica
Tom Daschle is a former Senate majority and minority leader, a public policy advisor, and a co-chair of BPC's Commission on Political Reform and Health Project. He has expertise on health care, energy, transportation, and the environment, and serves on several boards and committees.
15 ott 2021 · The former Democratic senator and Majority Leader shares his experience and advice on bipartisanship in today's divided Congress. He also discusses his personal involvement in biodefense issues after surviving an anthrax attack in 2001.
